Investigating the association between a history of depression and biomarkers of Alzheimer’s disease, cerebrovascular disease, and neurodegeneration in patients with dementia

The association between depression and dementia, particularly Alzheimer’s disease (AD) and cerebrovascular disease (CVD), remains an active area of research. This study aimed to investigate the relationship between a history of depression and biomarkers of AD and CVD in patients with dementia in a c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:GeroScience 2024-02, Vol.46 (1), p.783-793
Hauptverfasser: Salwierz, Patrick, Thapa, Simrika, Taghdiri, Foad, Vasilevskaya, Anna, Anastassiadis, Chloe, Tang-Wai, David F., Golas, Angela C., Tartaglia, M. Carmela
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 793
container_issue 1
container_start_page 783
container_title GeroScience
container_volume 46
creator Salwierz, Patrick
Thapa, Simrika
Taghdiri, Foad
Vasilevskaya, Anna
Anastassiadis, Chloe
Tang-Wai, David F.
Golas, Angela C.
Tartaglia, M. Carmela
description The association between depression and dementia, particularly Alzheimer’s disease (AD) and cerebrovascular disease (CVD), remains an active area of research. This study aimed to investigate the relationship between a history of depression and biomarkers of AD and CVD in patients with dementia in a clinical setting. A total of 126 patients from the University Health Network (UHN) Memory Clinic with comprehensive clinical evaluations, including neuropsychological testing and medical examinations, were included. Lumbar puncture was performed to collect cerebrospinal fluid (CSF) for biomarker analysis, and brain magnetic resonance imaging (MRI) scans were obtained to assess white matter hyperintensity (WMH) burden. The presence of depression was determined through medical records. The study findings did not reveal significant differences between participants with and without a history of depression in terms of AD biomarkers, WMH burden, neurofilament light chain levels, cognitive scores, age of symptom onset, disease duration, or vascular risk scores. Logistic regression analysis did not indicate a meaningful predictive value of these variables for depression status. This clinical study contributes to our understanding regarding the association between depression and AD/CVD biomarkers in patients with cognitive impairment. Further research is needed to elucidate the complex relationship between depression and dementia and to explore the potential mechanisms linking depression, AD, and CVD.
doi_str_mv 10.1007/s11357-023-01030-x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10828163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2902938598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-6dfb4a9b8a920594575d82bbd5ae949cb0e007725ace34e3d9636a8a0ad55e093</originalsourceid><addsrcrecordid>eNp9UkFu1TAQjRCIVqUXYIEssWFBYGLHSbxCVVVKpUpsYG05yfzEJbE_nuS3ZcU1OAV36klwSGkLC1Ye6715b2b0kuR5Bm8ygPItZZmQZQpcpJCBgPTqUbLPJaiUl1w8flDvJYdEFwCQlUUhAJ4me6ICVVZS7ic_z9wOabKdmazr2NQjM0S-sfHvHatxukR0zLDe0uTDNfMb1uI2INGCG9ey2vrRhC8YaAGPhm892hHDzfcfxFpLaAhfswYD1sHvDDXzYMI9sCg4nINvsUOHYfW1jm1jhW4idmmnPnqO8WPNs-TJxgyEh7fvQfL5_cmn4w_p-cfTs-Oj87TJRTalRbupc6PqyigOUuWylG3F67qVBlWumhowHrHk0jQochStKkRhKgOmlRJBiYPk3aq7nesR2yaaBzPobbBx12vtjdV_I872uvM7nUHFq6wQUeHVrULwX-d4Yz1aanAYjEM_k-YKuBKVVFWkvvyHeuHn4OJ-kcWBc5HLZSS-sprgiQJu7qbJQC-Z0GsmdMyE_p0JfRWbXjzc467lTwIiQawEipDrMNx7_0f2F7mgyOg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920223459</pqid></control><display><type>article</type><title>Investigating the association between a history of depression and biomarkers of Alzheimer’s disease, cerebrovascular disease, and neurodegeneration in patients with dementia</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Salwierz, Patrick ; Thapa, Simrika ; Taghdiri, Foad ; Vasilevskaya, Anna ; Anastassiadis, Chloe ; Tang-Wai, David F. ; Golas, Angela C. ; Tartaglia, M. Carmela</creator><creatorcontrib>Salwierz, Patrick ; Thapa, Simrika ; Taghdiri, Foad ; Vasilevskaya, Anna ; Anastassiadis, Chloe ; Tang-Wai, David F. ; Golas, Angela C. ; Tartaglia, M. Carmela</creatorcontrib><description>The association between depression and dementia, particularly Alzheimer’s disease (AD) and cerebrovascular disease (CVD), remains an active area of research. This study aimed to investigate the relationship between a history of depression and biomarkers of AD and CVD in patients with dementia in a clinical setting. A total of 126 patients from the University Health Network (UHN) Memory Clinic with comprehensive clinical evaluations, including neuropsychological testing and medical examinations, were included. Lumbar puncture was performed to collect cerebrospinal fluid (CSF) for biomarker analysis, and brain magnetic resonance imaging (MRI) scans were obtained to assess white matter hyperintensity (WMH) burden. The presence of depression was determined through medical records. The study findings did not reveal significant differences between participants with and without a history of depression in terms of AD biomarkers, WMH burden, neurofilament light chain levels, cognitive scores, age of symptom onset, disease duration, or vascular risk scores. Logistic regression analysis did not indicate a meaningful predictive value of these variables for depression status. This clinical study contributes to our understanding regarding the association between depression and AD/CVD biomarkers in patients with cognitive impairment. Further research is needed to elucidate the complex relationship between depression and dementia and to explore the potential mechanisms linking depression, AD, and CVD.</description><identifier>ISSN: 2509-2723</identifier><identifier>ISSN: 2509-2715</identifier><identifier>EISSN: 2509-2723</identifier><identifier>DOI: 10.1007/s11357-023-01030-x</identifier><identifier>PMID: 38097855</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Alzheimer's disease ; Biomarkers ; Biomedical and Life Sciences ; Cell Biology ; Cerebrospinal fluid ; Cerebrovascular disease ; Cerebrovascular diseases ; Cognitive ability ; Dementia ; Dementia disorders ; Geriatrics/Gerontology ; Life Sciences ; Magnetic resonance imaging ; Measuring techniques ; Medical records ; Molecular Medicine ; Neurodegenerative diseases ; Neuroimaging ; Original ; Original Article ; Patients ; Psychology ; Substantia alba</subject><ispartof>GeroScience, 2024-02, Vol.46 (1), p.783-793</ispartof><rights>The Author(s), under exclusive licence to American Aging Association 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to American Aging Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-6dfb4a9b8a920594575d82bbd5ae949cb0e007725ace34e3d9636a8a0ad55e093</citedby><cites>FETCH-LOGICAL-c431t-6dfb4a9b8a920594575d82bbd5ae949cb0e007725ace34e3d9636a8a0ad55e093</cites><orcidid>0009-0005-8599-1468</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10828163/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10828163/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,41488,42557,51319,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38097855$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salwierz, Patrick</creatorcontrib><creatorcontrib>Thapa, Simrika</creatorcontrib><creatorcontrib>Taghdiri, Foad</creatorcontrib><creatorcontrib>Vasilevskaya, Anna</creatorcontrib><creatorcontrib>Anastassiadis, Chloe</creatorcontrib><creatorcontrib>Tang-Wai, David F.</creatorcontrib><creatorcontrib>Golas, Angela C.</creatorcontrib><creatorcontrib>Tartaglia, M. Carmela</creatorcontrib><title>Investigating the association between a history of depression and biomarkers of Alzheimer’s disease, cerebrovascular disease, and neurodegeneration in patients with dementia</title><title>GeroScience</title><addtitle>GeroScience</addtitle><addtitle>Geroscience</addtitle><description>The association between depression and dementia, particularly Alzheimer’s disease (AD) and cerebrovascular disease (CVD), remains an active area of research. This study aimed to investigate the relationship between a history of depression and biomarkers of AD and CVD in patients with dementia in a clinical setting. A total of 126 patients from the University Health Network (UHN) Memory Clinic with comprehensive clinical evaluations, including neuropsychological testing and medical examinations, were included. Lumbar puncture was performed to collect cerebrospinal fluid (CSF) for biomarker analysis, and brain magnetic resonance imaging (MRI) scans were obtained to assess white matter hyperintensity (WMH) burden. The presence of depression was determined through medical records. The study findings did not reveal significant differences between participants with and without a history of depression in terms of AD biomarkers, WMH burden, neurofilament light chain levels, cognitive scores, age of symptom onset, disease duration, or vascular risk scores. Logistic regression analysis did not indicate a meaningful predictive value of these variables for depression status. This clinical study contributes to our understanding regarding the association between depression and AD/CVD biomarkers in patients with cognitive impairment. Further research is needed to elucidate the complex relationship between depression and dementia and to explore the potential mechanisms linking depression, AD, and CVD.</description><subject>Alzheimer's disease</subject><subject>Biomarkers</subject><subject>Biomedical and Life Sciences</subject><subject>Cell Biology</subject><subject>Cerebrospinal fluid</subject><subject>Cerebrovascular disease</subject><subject>Cerebrovascular diseases</subject><subject>Cognitive ability</subject><subject>Dementia</subject><subject>Dementia disorders</subject><subject>Geriatrics/Gerontology</subject><subject>Life Sciences</subject><subject>Magnetic resonance imaging</subject><subject>Measuring techniques</subject><subject>Medical records</subject><subject>Molecular Medicine</subject><subject>Neurodegenerative diseases</subject><subject>Neuroimaging</subject><subject>Original</subject><subject>Original Article</subject><subject>Patients</subject><subject>Psychology</subject><subject>Substantia alba</subject><issn>2509-2723</issn><issn>2509-2715</issn><issn>2509-2723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9UkFu1TAQjRCIVqUXYIEssWFBYGLHSbxCVVVKpUpsYG05yfzEJbE_nuS3ZcU1OAV36klwSGkLC1Ye6715b2b0kuR5Bm8ygPItZZmQZQpcpJCBgPTqUbLPJaiUl1w8flDvJYdEFwCQlUUhAJ4me6ICVVZS7ic_z9wOabKdmazr2NQjM0S-sfHvHatxukR0zLDe0uTDNfMb1uI2INGCG9ey2vrRhC8YaAGPhm892hHDzfcfxFpLaAhfswYD1sHvDDXzYMI9sCg4nINvsUOHYfW1jm1jhW4idmmnPnqO8WPNs-TJxgyEh7fvQfL5_cmn4w_p-cfTs-Oj87TJRTalRbupc6PqyigOUuWylG3F67qVBlWumhowHrHk0jQochStKkRhKgOmlRJBiYPk3aq7nesR2yaaBzPobbBx12vtjdV_I872uvM7nUHFq6wQUeHVrULwX-d4Yz1aanAYjEM_k-YKuBKVVFWkvvyHeuHn4OJ-kcWBc5HLZSS-sprgiQJu7qbJQC-Z0GsmdMyE_p0JfRWbXjzc467lTwIiQawEipDrMNx7_0f2F7mgyOg</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Salwierz, Patrick</creator><creator>Thapa, Simrika</creator><creator>Taghdiri, Foad</creator><creator>Vasilevskaya, Anna</creator><creator>Anastassiadis, Chloe</creator><creator>Tang-Wai, David F.</creator><creator>Golas, Angela C.</creator><creator>Tartaglia, M. Carmela</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0009-0005-8599-1468</orcidid></search><sort><creationdate>20240201</creationdate><title>Investigating the association between a history of depression and biomarkers of Alzheimer’s disease, cerebrovascular disease, and neurodegeneration in patients with dementia</title><author>Salwierz, Patrick ; Thapa, Simrika ; Taghdiri, Foad ; Vasilevskaya, Anna ; Anastassiadis, Chloe ; Tang-Wai, David F. ; Golas, Angela C. ; Tartaglia, M. Carmela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-6dfb4a9b8a920594575d82bbd5ae949cb0e007725ace34e3d9636a8a0ad55e093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Alzheimer's disease</topic><topic>Biomarkers</topic><topic>Biomedical and Life Sciences</topic><topic>Cell Biology</topic><topic>Cerebrospinal fluid</topic><topic>Cerebrovascular disease</topic><topic>Cerebrovascular diseases</topic><topic>Cognitive ability</topic><topic>Dementia</topic><topic>Dementia disorders</topic><topic>Geriatrics/Gerontology</topic><topic>Life Sciences</topic><topic>Magnetic resonance imaging</topic><topic>Measuring techniques</topic><topic>Medical records</topic><topic>Molecular Medicine</topic><topic>Neurodegenerative diseases</topic><topic>Neuroimaging</topic><topic>Original</topic><topic>Original Article</topic><topic>Patients</topic><topic>Psychology</topic><topic>Substantia alba</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salwierz, Patrick</creatorcontrib><creatorcontrib>Thapa, Simrika</creatorcontrib><creatorcontrib>Taghdiri, Foad</creatorcontrib><creatorcontrib>Vasilevskaya, Anna</creatorcontrib><creatorcontrib>Anastassiadis, Chloe</creatorcontrib><creatorcontrib>Tang-Wai, David F.</creatorcontrib><creatorcontrib>Golas, Angela C.</creatorcontrib><creatorcontrib>Tartaglia, M. Carmela</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>GeroScience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salwierz, Patrick</au><au>Thapa, Simrika</au><au>Taghdiri, Foad</au><au>Vasilevskaya, Anna</au><au>Anastassiadis, Chloe</au><au>Tang-Wai, David F.</au><au>Golas, Angela C.</au><au>Tartaglia, M. Carmela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Investigating the association between a history of depression and biomarkers of Alzheimer’s disease, cerebrovascular disease, and neurodegeneration in patients with dementia</atitle><jtitle>GeroScience</jtitle><stitle>GeroScience</stitle><addtitle>Geroscience</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>46</volume><issue>1</issue><spage>783</spage><epage>793</epage><pages>783-793</pages><issn>2509-2723</issn><issn>2509-2715</issn><eissn>2509-2723</eissn><abstract>The association between depression and dementia, particularly Alzheimer’s disease (AD) and cerebrovascular disease (CVD), remains an active area of research. This study aimed to investigate the relationship between a history of depression and biomarkers of AD and CVD in patients with dementia in a clinical setting. A total of 126 patients from the University Health Network (UHN) Memory Clinic with comprehensive clinical evaluations, including neuropsychological testing and medical examinations, were included. Lumbar puncture was performed to collect cerebrospinal fluid (CSF) for biomarker analysis, and brain magnetic resonance imaging (MRI) scans were obtained to assess white matter hyperintensity (WMH) burden. The presence of depression was determined through medical records. The study findings did not reveal significant differences between participants with and without a history of depression in terms of AD biomarkers, WMH burden, neurofilament light chain levels, cognitive scores, age of symptom onset, disease duration, or vascular risk scores. Logistic regression analysis did not indicate a meaningful predictive value of these variables for depression status. This clinical study contributes to our understanding regarding the association between depression and AD/CVD biomarkers in patients with cognitive impairment. Further research is needed to elucidate the complex relationship between depression and dementia and to explore the potential mechanisms linking depression, AD, and CVD.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>38097855</pmid><doi>10.1007/s11357-023-01030-x</doi><tpages>11</tpages><orcidid>https://orcid.org/0009-0005-8599-1468</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2509-2723
ispartof GeroScience, 2024-02, Vol.46 (1), p.783-793
issn 2509-2723
2509-2715
2509-2723
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10828163
source PubMed Central; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings
subjects Alzheimer's disease
Biomarkers
Biomedical and Life Sciences
Cell Biology
Cerebrospinal fluid
Cerebrovascular disease
Cerebrovascular diseases
Cognitive ability
Dementia
Dementia disorders
Geriatrics/Gerontology
Life Sciences
Magnetic resonance imaging
Measuring techniques
Medical records
Molecular Medicine
Neurodegenerative diseases
Neuroimaging
Original
Original Article
Patients
Psychology
Substantia alba
title Investigating the association between a history of depression and biomarkers of Alzheimer’s disease, cerebrovascular disease, and neurodegeneration in patients with dementia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A52%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Investigating%20the%20association%20between%20a%20history%20of%20depression%20and%20biomarkers%20of%20Alzheimer%E2%80%99s%20disease,%20cerebrovascular%20disease,%20and%20neurodegeneration%20in%20patients%20with%20dementia&rft.jtitle=GeroScience&rft.au=Salwierz,%20Patrick&rft.date=2024-02-01&rft.volume=46&rft.issue=1&rft.spage=783&rft.epage=793&rft.pages=783-793&rft.issn=2509-2723&rft.eissn=2509-2723&rft_id=info:doi/10.1007/s11357-023-01030-x&rft_dat=%3Cproquest_pubme%3E2902938598%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920223459&rft_id=info:pmid/38097855&rfr_iscdi=true